Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Caranobe

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Thrombosis Research|September 15, 1986
Heparin fractions with high and low affinities to antithrombin III are cleared at different ratesC Caranobe, M Petitou, D Dupouy, et al.
European Journal of Clinical Investigation|December 1, 1985
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatmentA Villeneuve, M Berlan, M Lafontan, et al.
Thrombosis and Haemostasis|April 22, 1985
Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative studyA Boneu, P Sié, R Bugat, et al.
Thrombosis Research|June 15, 1987
Evidence for a saturable mechanism of disappearance of standard heparin in rabbitsB Boneu, C Caranobe, A M Gabaig, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1992
Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Scandinavian Journal of Haematology|September 1, 1980
Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function testsB Boneu, C Nouvel, P Sie, et al.
Thrombosis Research|October 15, 1988
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological propertiesF Dol, C Caranobe, D Dupouy, et al.
Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.
Thrombosis and Haemostasis|March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Thrombosis Research|September 15, 1986
Heparin fractions with high and low affinities to antithrombin III are cleared at different ratesC Caranobe, M Petitou, D Dupouy, et al.
European Journal of Clinical Investigation|December 1, 1985
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatmentA Villeneuve, M Berlan, M Lafontan, et al.
Thrombosis and Haemostasis|April 22, 1985
Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative studyA Boneu, P Sié, R Bugat, et al.
Thrombosis Research|June 15, 1987
Evidence for a saturable mechanism of disappearance of standard heparin in rabbitsB Boneu, C Caranobe, A M Gabaig, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1992
Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Scandinavian Journal of Haematology|September 1, 1980
Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function testsB Boneu, C Nouvel, P Sie, et al.
Thrombosis Research|October 15, 1988
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological propertiesF Dol, C Caranobe, D Dupouy, et al.
Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.
Thrombosis and Haemostasis|March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.
Pageof 6